ALPHA TRIBE

Alembic Pharmaceuticals LimitedBoard Meeting, 04-08-2026: Outcome of Board Meeting

04-08-2026 | 02:05 pm

Alembic Pharmaceuticals' Board approved Q1 financial results. Consolidated Revenue from Operations stood at ₹2,149.77 Cr, with Net Profit at ₹175.33 Cr for the quarter. EPS was ₹8.80.

No comments yet. Be the first to comment!

All announcements from Alembic Pharmaceuticals Limited